Urologic Imaging

Should You Order Imaging for Transient Hematospermia in a Man Under 40?

·
Should You Order Imaging for Transient Hematospermia in a Man Under 40?

A 32-year-old male presents to your clinic with a chief complaint of “blood in my semen.” He noticed it once, last week, and has not seen it since. He is understandably anxious but is otherwise in excellent health. He denies any pain, urinary symptoms, fever, history of trauma, or personal or family history of urologic malignancy. You perform a physical exam, which is entirely normal. The immediate question is whether this isolated, transient finding in a young, healthy man warrants an imaging workup.

This scenario—a male under 40 with transient hematospermia and no other signs or symptoms—is a common clinical presentation that often causes more patient anxiety than it represents true pathology. According to the American College of Radiology (ACR) Appropriateness Criteria, the evidence-based answer is clear: for this specific presentation, advanced imaging is Usually Not Appropriate. This article details the clinical workflow, the rationale for avoiding imaging, and the appropriate management for this low-risk patient population.

Who Fits This Clinical Scenario?

This guidance applies to a very specific patient profile. It is critical to ensure your patient meets all the inclusion criteria before deferring an imaging workup.

Inclusion Criteria for This Workflow:

  • Age: The patient must be less than 40 years old.
  • Presentation: The hematospermia is transient (e.g., a single episode or a few episodes over a very short period that have resolved).
  • Associated Factors: There are no other associated signs or symptoms. This includes the absence of a palpable abnormality on genital or digital rectal exam, no lower urinary tract symptoms (LUTS), no signs of infection (fever, dysuria), no recent trauma, and no risk factors for malignancy.

Exclusion Criteria (These Patients Require a Different Workup):

  • Age ≥ 40: Men aged 40 and older have a higher pre-test probability of significant pathology, such as prostate cancer. Their workup follows a different ACR pathway.
  • Persistent or Recurrent Hematospermia: If the symptom does not resolve or if it recurs over several weeks or months, it is no longer considered transient and warrants investigation regardless of age.
  • Associated Signs or Symptoms: The presence of a palpable mass, significant LUTS, suspected infection (prostatitis, epididymitis, urethritis), or a history of pelvic trauma immediately moves the patient into a higher-risk category requiring a different evaluation.

What Diagnoses Are You Working Up in This Scenario?

In a young man with isolated, transient hematospermia, the differential diagnosis is overwhelmingly benign and often self-limiting. The primary goal of the initial clinical evaluation is to rule out red flags and provide reassurance, not to hunt for rare pathology with low-yield imaging.

The most common cause is idiopathic. In many cases, a definitive source is never found, and the condition resolves spontaneously without consequence. This is the presumed diagnosis in the majority of men under 40 who fit this clinical picture.

Another frequent cause is inflammation or infection. Subclinical prostatitis or urethritis can cause minor bleeding that manifests as hematospermia. This may follow a recent, even unrecognized, urinary tract infection or sexually transmitted infection. The inflammation irritates the delicate vasculature of the prostate, seminal vesicles, or ejaculatory ducts.

Iatrogenic or traumatic causes are also possible. This can include vigorous sexual activity or minor, unreported trauma to the perineum. In some cases, recent urologic procedures, such as a prostate biopsy, are an obvious cause, but this scenario assumes no such recent history.

Less common but still benign considerations include prostatic or ejaculatory duct cysts and calculi within the seminal vesicles or prostate. These are structural anomalies that can occasionally cause bleeding but are often incidental findings if imaging is performed. Malignancy of the prostate, bladder, or testes is exceedingly rare as a cause of isolated hematospermia in this age group and is not a primary consideration without other risk factors.

Why Is Imaging Usually Not Appropriate for This Presentation?

For a male under 40 with transient, asymptomatic hematospermia, the ACR rates all advanced imaging modalities—including Transrectal Ultrasound (TRUS), MRI, and CT—as Usually Not Appropriate. The rationale is grounded in the principles of appropriate use: the extremely low pre-test probability of finding a clinically significant, treatable abnormality is far outweighed by the costs, potential for incidental findings, and patient anxiety associated with imaging.

  • Transrectal Ultrasound (TRUS) of the Prostate: While TRUS can visualize the prostate, seminal vesicles, and ejaculatory ducts, its yield in this specific low-risk scenario is minimal. The likelihood of finding a condition that requires intervention (e.g., a large, symptomatic cyst or a tumor) is negligible. Therefore, the ACR rates TRUS as Usually Not Appropriate.
  • Magnetic Resonance Imaging (MRI) of the Pelvis: MRI offers excellent soft-tissue contrast and is a powerful tool for evaluating pelvic anatomy. However, it is a high-cost, resource-intensive study. Ordering an MRI for this indication would lead to over-investigation for a benign, self-limiting condition. Both MRI of the pelvis without IV contrast (0 mSv) and with IV contrast (0 mSv) are rated Usually Not Appropriate.
  • Computed Tomography (CT) of the Abdomen and Pelvis: CT is a poor choice for evaluating the internal architecture of the prostate and seminal vesicles. More importantly, it involves ionizing radiation. A CT of the abdomen and pelvis with IV contrast carries a radiation dose of 1-10 mSv (ACR RRL ☢☢☢). Given the benign nature of the underlying condition, exposing a young patient to this radiation is not justified. Consequently, all variants of CT are rated Usually Not Appropriate.

The core principle is clinical stratification. This patient presentation represents the lowest-risk category, where a strategy of watchful waiting and patient reassurance is superior to an immediate imaging workup.

What’s Next Without Imaging? The Downstream Workflow

Since imaging is not indicated, the workflow is entirely clinical. The focus shifts from investigation to education, reassurance, and establishing clear parameters for follow-up.

  • If the Presentation is Classic (Transient, Asymptomatic, <40): The primary next step is patient reassurance. Explain that isolated hematospermia in his age group is common, almost always benign, and typically resolves on its own. A detailed history and a normal physical exam are sufficient for the initial evaluation. No further workup is needed at this time.
  • Provide Clear Follow-up Instructions: Instruct the patient to return if the hematospermia persists for more than one to two months, if it becomes recurrent after resolving, or if he develops any new symptoms such as pain, fever, voiding difficulties, or a palpable lump. This creates a safety net and empowers the patient.
  • If the Hematospermia Persists or Recurs: If the patient returns because the condition did not resolve or has recurred, he no longer fits this low-risk scenario. He now falls into the ACR variant for “persistent or recurrent hematospermia.” At this point, the workup should be escalated. This typically involves a referral to urology and consideration of imaging, starting with TRUS of the prostate, which becomes appropriate in the setting of persistent symptoms.

Pitfalls to Avoid (and When to Escalate)

Managing this condition effectively requires avoiding common missteps that can lead to unnecessary tests and patient anxiety.

  • Pitfall 1: Ordering Imaging Prematurely. The most common error is reacting to the patient’s anxiety by ordering an ultrasound or CT scan. This goes against evidence-based guidelines and has a high probability of being unrevealing or showing only incidental findings.
  • Pitfall 2: Incomplete History or Exam. Do not assume the case is benign without confirming the absence of red flags. A thorough history should cover trauma, infections, and constitutional symptoms. The physical exam must include a genital and digital rectal exam (as appropriate) to rule out palpable abnormalities.
  • Pitfall 3: Failing to Provide Adequate Reassurance. Simply telling the patient “it’s nothing” can be dismissive. Explaining why it is considered benign in his specific context can significantly reduce anxiety and improve adherence to a watchful waiting plan.

Escalate immediately to a urology consultation if the physical exam reveals any abnormality (e.g., a testicular mass, a nodular prostate) or if the patient’s history suggests a higher-risk profile that was not initially apparent.

Related ACR Topics and Tools

For a comprehensive overview of all clinical scenarios related to hematospermia, including workflows for older or symptomatic patients, please see our parent guide. For additional tools to help with imaging decisions, the following resources are available.

Frequently Asked Questions

Is any blood work necessary for a man under 40 with transient hematospermia?

Generally, no. If the history and physical exam are unremarkable, blood work such as a PSA (Prostate-Specific Antigen) test, CBC, or coagulation studies is not indicated. PSA screening is not recommended for men under 40 without significant risk factors, and the pre-test probability of a coagulopathy presenting this way is extremely low.

What if the patient is extremely anxious and insists on an imaging study?

This requires a careful conversation about the risks and benefits. Explain that for his specific presentation, the ACR guidelines recommend against imaging because the chance of finding a dangerous condition is exceptionally low, while the risks of false positives, unnecessary anxiety, and further invasive procedures are real. Shared decision-making is key, but it should be guided by evidence.

Does a history of a sexually transmitted infection (STI) change the initial management?

Yes, potentially. If there is any suspicion of an active STI (e.g., urethral discharge, dysuria, high-risk sexual history), then a workup for urethritis or prostatitis is warranted, which would include STI testing. This is still a clinical and laboratory diagnosis, and imaging is typically not the first step unless the infection is complicated.

How long is ‘transient’? When does it become ‘persistent’?

While there is no strict definition, ‘transient’ generally implies one or a few episodes that resolve completely within a few weeks (typically less than a month). If the hematospermia is present in most ejaculations for over a month or if it resolves and then recurs multiple times, it should be considered ‘persistent’ or ‘recurrent’ and warrants further evaluation.

Should I refer this patient to a urologist on the first visit?

For a patient who perfectly fits this low-risk scenario (under 40, transient, no other symptoms, normal exam), a referral to urology is generally not necessary on the first visit. The condition can be confidently managed in a primary care or urgent care setting with reassurance and clear follow-up instructions. A referral is appropriate if the hematospermia persists, recurs, or if any red flags are present.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026